Showing results (441-450 of 498) with videos related to

Sort By:
Pageof 50
Nature Immunology|January 11, 2012
NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8⁺ T cellsAndreas Kupz, Greta Guarda, Thomas Gebhardt, et al.
The Journal of Infectious Diseases|November 1, 2019
Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017Heidi M Soeters, Dinanibè Kambiré, Guetawendé Sawadogo, et al.
The American Journal of Tropical Medicine and Hygiene|April 1, 2025
Development and Internal Validation of a Risk Assessment Tool to Identify Neonates at Risk for 60-Day Hospital Readmission in Dar es Salaam, Tanzania, and Monrovia, LiberiaRodrick R Kisenge, Evance Godfrey, Readon C Ideh, et al.
BMJ Paediatrics Open|November 10, 2025
Advancing approaches to identify young children at risk for post-discharge mortality: Protocol for a prospective observational cohort study in Western KenyaKitiezo Aggrey Igunza, Adrianna L Westbrook, Harun Owuor, et al.
BMC Infectious Diseases|January 7, 2017
Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010Miwako Kobayashi, Laura M Conklin, Godfrey Bigogo, et al.
BMJ Paediatrics Open|June 20, 2025
Machine learning approaches to identify neonates and young children at risk for postdischarge mortality in Dar es Salaam, Tanzania and Monrovia, LiberiaChris A Rees, Rodrick Kisenge, Evance Godfrey, et al.
The Pediatric Infectious Disease Journal|July 4, 2014
Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012Claire von Mollendorf, Cheryl Cohen, Linda de Gouveia, et al.
MMWR. Morbidity and Mortality Weekly Report|March 6, 2015
Systems for rapidly detecting and treating persons with ebola virus disease--United StatesLisa M Koonin, Denise J Jamieson, John A Jernigan, et al.
The Lancet. Respiratory Medicine|March 19, 2016
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control studyMatthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
The Lancet. Global Health|February 1, 2017
Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control studyCheryl Cohen, Claire von Mollendorf, Linda de Gouveia, et al.
Pageof 50